Showing results (321-330 of 668) with videos related to

Sort By:
Pageof 67
Diabetology International|August 5, 2024
Immune checkpoint inhibitor-related type 1 diabetes mellitus which develops long after treatment discontinuation: a case report and review of literatureYoshinari Obata, Miho Takemoto, Taka-Aki Sakaue, et al.
Diabetology International|August 5, 2024
Advances in basic research on glucagon and alpha cellsYoshitaka Hayashi
Diabetology International|April 1, 2025
Case-based learning: a case of maturity-onset diabetes of the young 5 (MODY5) due to 17q12 microdeletion with a diminished plasma glucagon levelYoko Sugano, Motohiro Sekiya, Yuki Murayama, et al.
Diabetology International|April 1, 2025
Impact of a COVID-19 emergency declaration on blood glucose levels in individuals with type 1 diabetes treated with a sensor-augmented pumpTomofumi Takayoshi, Yushi Hirota, Akane Yamamoto, et al.
Diabetology International|April 1, 2025
Decoding MODY: exploring genetic roots and clinical pathwaysAnshuman Phadnis, Diya Chawla, Joanne Alex, et al.
Diabetology International|April 1, 2025
Perception of hyper-/hypoglycemia and its related factors in type 2 diabetes: a continuous glucose monitoring-based prospective observational studyYuka Suzuki, Aika Miya, Akinobu Nakamura, et al.
Diabetology International|April 1, 2025
Association between the type of family history of diabetes and the risk and age at onset of diabetes in the Japanese general populationMinoru Iwata, Teruyo Okazawa, Kiyohiro Higuchi, et al.
Diabetology International|April 1, 2025
Association among the number of natural teeth, dental maintenance visits and diabetes status: a cross-sectional study using employment-based healthcare claims databaseMiki Ishikawa, Takako Yasuda, Natsuki Nara, et al.
Diabetology International|April 1, 2025
Exploring the significance of phase angle in diabetes management: a narrative reviewMahboobeh Ghasemzadeh Rahbardar, Gordon A Ferns, Majid Ghayour Mobarhan
Diabetology International|April 1, 2025
Immune checkpoint inhibitor-related type 1 diabetes mellitus with closely monitored dynamics of glutamic acid decarboxylase antibody levels before and after disease onsetTaka-Aki Sakaue, Yoshinari Obata, Kumiko Sakai, et al.
Pageof 67